These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7294572)

  • 1. Hypertriglyceridemia associated with thrombocytopenia and lipoprotein lipase deficiency.
    Romics L
    Ann Intern Med; 1981 Nov; 95(5):660-1. PubMed ID: 7294572
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogenesis of type I hyperlipoproteinemia.
    Gnasso A; Koch H; Haberbosch W; Fellin R; Postiglione A; Augustin J
    Monogr Atheroscler; 1986; 14():135-9. PubMed ID: 3736552
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lipoprotein lipase deficiency in 2 young patients (hyperlipoproteinemia type I)].
    Bakker HD; Abeling NG; Rammeloo JA; Jansen H; van Gennip AH
    Ned Tijdschr Geneeskd; 1985 Apr; 129(14):642-5. PubMed ID: 3990858
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hyperlipoproteinemia type I].
    Bustos P; Fernández E; Radrigán E
    Rev Chil Pediatr; 1987; 58(6):481-4. PubMed ID: 3506219
    [No Abstract]   [Full Text] [Related]  

  • 5. [Primary hyperlipoproteinemia type 1].
    Yamamura T
    Nihon Rinsho; 1983 Aug; 41(8):1793-8. PubMed ID: 6632287
    [No Abstract]   [Full Text] [Related]  

  • 6. The plasma lipoproteins in familial chylomicronemia. Analysis by zonal ultracentrifugation.
    Manzato E; Marin R; Gasparotto A; Baggio G; Fellin R; Crepaldi G
    J Lab Clin Med; 1984 Nov; 104(5):778-88. PubMed ID: 6491471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 1 hyperlipoproteinaemia and pregnancy.
    Potter JM; Michael CA
    Aust N Z J Obstet Gynaecol; 1982 Aug; 22(3):155-8. PubMed ID: 6184045
    [No Abstract]   [Full Text] [Related]  

  • 8. Feasibility and metabolic effects of a purified corn fiber food supplement.
    Earll L; Earll JM; Naujokaitis S; Pyle S; Mc Falls K; Altschul AM
    J Am Diet Assoc; 1988 Aug; 88(8):950-2. PubMed ID: 2840458
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary hypertriglyceridemia in childhood.
    Deckelbaum RJ; Dupont C; LeTarte J; Pencharz P
    Am J Dis Child; 1983 Apr; 137(4):396-8. PubMed ID: 6829521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary type I hyperlipoproteinaemia--a metabolic and family study.
    Potter JM; Macdonald WB
    Aust N Z J Med; 1979 Dec; 9(6):688-93. PubMed ID: 294927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hyperlipoproteinemias.
    Crepaldi G; Baggio G; Manzato E
    Ann Ital Med Int; 1986; 1 Suppl 1():1-5. PubMed ID: 3079432
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
    Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV
    J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chylomicron and very-low-density lipoprotein levels in type I hyperlipoproteinaemia. The role of the liver in determining biochemical phenotype.
    Berger GM; Van der Westhuyzen JH; Huskisson J; Bonnici F; Henderson HE
    S Afr Med J; 1982 Feb; 61(8):266-72. PubMed ID: 7058458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperchylomicronemia in a premature infant].
    Hurgoiu V; David-Mark S
    Rev Pediatr Obstet Ginecol Pediatr; 1987; 36(4):341-4. PubMed ID: 3125587
    [No Abstract]   [Full Text] [Related]  

  • 15. Intramuscular administration of AAV1-lipoprotein lipase S447X lowers triglycerides in lipoprotein lipase-deficient patients.
    Stroes ES; Nierman MC; Meulenberg JJ; Franssen R; Twisk J; Henny CP; Maas MM; Zwinderman AH; Ross C; Aronica E; High KA; Levi MM; Hayden MR; Kastelein JJ; Kuivenhoven JA
    Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2303-4. PubMed ID: 18802015
    [No Abstract]   [Full Text] [Related]  

  • 16. Apolipoprotein CII in type I hyperlipoproteinemia. A study in three cases.
    Kashyap ML; Srivastava LS; Tsang RC; Taskinen MR; Hynd BA; Perisutti G; Brady DW; Glueck CJ; Ahumada CA; McCarthy JA; Sosa RA; Reeds TO
    J Lab Clin Med; 1980 Feb; 95(2):180-7. PubMed ID: 7354231
    [No Abstract]   [Full Text] [Related]  

  • 17. A novel apolipoprotein C-II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E-knockout mice.
    Amar MJ; Sakurai T; Sakurai-Ikuta A; Sviridov D; Freeman L; Ahsan L; Remaley AT
    J Pharmacol Exp Ther; 2015 Feb; 352(2):227-35. PubMed ID: 25395590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cholesterol and triglyceride content of lipoproteins in hyperlipoproteinemia type II/a, II/b and IV].
    Romics L; Karádi I; Simonyi E
    Orv Hetil; 1980 Oct; 121(43):2629-31. PubMed ID: 7208011
    [No Abstract]   [Full Text] [Related]  

  • 19. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene.
    Benlian P; De Gennes JL; Foubert L; Zhang H; Gagné SE; Hayden M
    N Engl J Med; 1996 Sep; 335(12):848-54. PubMed ID: 8778602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and functional characterization of familial chylomicronemia syndrome.
    Teramoto R; Tada H; Kawashiri MA; Nohara A; Nakahashi T; Konno T; Inazu A; Mabuchi H; Yamagishi M; Hayashi K
    Atherosclerosis; 2018 Feb; 269():272-278. PubMed ID: 29153744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.